H19 and melanoma: In melanoma cells, the overexpression of lncRNA H19 [87] and of NEAT1 [88] leads to the acquired resistance to cisplatin through the direct targeting to the miR-18b/IGF1 and miR-519c-3p/MeCP2 axes, respectively.